Ignite Creation Date:
2024-05-06 @ 1:48 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01906385
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2012-01-11
Brief Title:
Maximum Tolerated Dose Safety and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma ReSPECT
Sponsor:
Plus Therapeutics
Organization:
Plus Therapeutics
Organization Data
Organization:
Plus Therapeutics
Class:
INDUSTRY
Study ID:
CTRC 12-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Plus Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |